Insmed
INSM
#1043
Rank
โ‚น2.203 T
Marketcap
โ‚น10,165
Share price
-3.00%
Change (1 day)
80.33%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2025 (TTM): -โ‚น104.65 Billion

According to Insmed's latest financial reports the company's current earnings are โ‚น0.60 Billion. a decrease over its 2024 earnings that were of -โ‚น79.4 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2025

Annual earnings

Year Earnings Change
2025 -โ‚น114.26 Billion43.91%
2024 -โ‚น79.4 Billion23.71%
2023 -โ‚น64.18 Billion45.77%
2022 -โ‚น44.03 Billion15.83%
2021 -โ‚น38.02 Billion50.19%
2020 -โ‚น25.31 Billion16.4%
2019 -โ‚น21.75 Billion-23.9%
2018 -โ‚น28.58 Billion59.35%
2017 -โ‚น17.93 Billion8.52%
2016 -โ‚น16.53 Billion47.25%
2015 -โ‚น11.22 Billion34.53%
2014 -โ‚น8.35 Billion58.83%
2013 -โ‚น5.26 Billion35.14%
2012 -โ‚น3.89 Billion-31.92%
2011 -โ‚น5.71 Billion854.92%
2010 -โ‚น0.6 Billion-105.22%
2009 โ‚น11.44 B-905.06%
2008 -โ‚น1.43 Billion-27.31%
2007 -โ‚น1.96 Billion-62.41%
2006 -โ‚น5.21 Billion98.19%
2005 -โ‚น2.63 Billion0.03%
2004 -โ‚น2.63 Billion159.07%
2003 -โ‚น1.02 Billion-69.31%
2002 -โ‚น3.31 Billion
2000 -โ‚น2.98 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚น1.510 T-1,421.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
โ‚น937.37 B-920.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น484.32 B-523.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-โ‚น67.19 Billion-41.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น2.23 Billion-98.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-โ‚น0.19 Billion-99.84%๐Ÿ‡บ๐Ÿ‡ธ USA